Skip to main content
Erschienen in: World Journal of Urology 4/2019

24.09.2018 | Topic Paper

Trends in penile prosthesis implantation and analysis of predictive factors for removal

verfasst von: Kai Li, Eileen R. Brandes, Steven L. Chang, Jeffrey J. Leow, Benjamin I. Chung, Ye Wang, Jairam R. Eswara

Erschienen in: World Journal of Urology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aims to analyze patient demographics, hospital characteristics, and clinical risk factors which predict penile prosthesis removal. We also examine costs of penile prosthesis removal and trends in inflatable versus non-inflatable penile prostheses implantation in the USA from 2003 to 2015.

Methods

Cross-sectional analysis from Premier Perspective Database was completed using data from 2003 to 2015. We compared the relative proportion of inflatable versus non-inflatable penile prostheses implanted. We separated the prosthesis removal group based on indication for removal—Group 1 (infection), Group 2 (mechanical complication), and Group 3 (all explants). All groups were compared to a control group of patients with penile implants who were never subsequently explanted. Multivariate analysis was performed to analyze patient and hospital factors which predicted removal. Cost comparison was performed between the explant groups.

Results

There were 5085 penile prostheses implanted with a stable relative proportion of inflatable versus non-inflatable prosthesis over the 13-year study period. There were 3317 explantations. Patient factors associated with prosthesis removal were non-black race, Charlson Comorbidity Index, diabetes, and HIV status. Hospital factors associated with removal included non-teaching status, hospital region, year of removal, and annual surgeon volume. Median hospitalization costs of all explantations were $10,878. Explantations due to infection cost $11,252 versus $8602 for mechanical complications.

Conclusions

This large population-based study demonstrates a stable trend in inflatable versus non-inflatable prosthesis implantation. We also identify patient and hospital factors that predict penile prosthesis removal which has clinical utility for patient risk stratification and counseling.
Literatur
2.
Zurück zum Zitat Wilson SK, Delk JR, Salem EA, Cleves MA (2007) Long-term survival of inflatable penile prostheses: single surgical group experience with 2,384 first-time implants spanning two decades. J Sex Med 4:1074–1079CrossRefPubMed Wilson SK, Delk JR, Salem EA, Cleves MA (2007) Long-term survival of inflatable penile prostheses: single surgical group experience with 2,384 first-time implants spanning two decades. J Sex Med 4:1074–1079CrossRefPubMed
3.
Zurück zum Zitat Trost L, Wanzek P, Bailey G (2016) A practical overview of considerations for penile prosthesis placement. Nat Rev Urol 12:33–46CrossRef Trost L, Wanzek P, Bailey G (2016) A practical overview of considerations for penile prosthesis placement. Nat Rev Urol 12:33–46CrossRef
4.
Zurück zum Zitat Chung E (2017) Penile prosthesis implant: scientific advances and technological innovations over the last four decades. Transl Androl Urol 6(1):37–45CrossRefPubMedPubMedCentral Chung E (2017) Penile prosthesis implant: scientific advances and technological innovations over the last four decades. Transl Androl Urol 6(1):37–45CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Nielsen KT, Bruskewitz RC (1989) Semirigid and malleable rod penile prostheses. Urol Clin N Am 16:13–23 Nielsen KT, Bruskewitz RC (1989) Semirigid and malleable rod penile prostheses. Urol Clin N Am 16:13–23
6.
Zurück zum Zitat Grewal S, Vetter J, Brandes SB, Strope SA (2014) A Population-based analysis of contemporary rates of reoperation for penile prosthesis procedures. Urology 84(1):112–116CrossRefPubMedPubMedCentral Grewal S, Vetter J, Brandes SB, Strope SA (2014) A Population-based analysis of contemporary rates of reoperation for penile prosthesis procedures. Urology 84(1):112–116CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Jarrow JP (1996) Risk factors for penile prosthetic infection. J Urol 156(2 Pt 1):402–404CrossRef Jarrow JP (1996) Risk factors for penile prosthetic infection. J Urol 156(2 Pt 1):402–404CrossRef
8.
Zurück zum Zitat Govier FE, Gibbons RP, Correa RJ, Pritchett TR, Kramer-Levien D (1998) Mechanical reliability, surgical complications and patients partner satisfaction of the modern three-piece inflatable penile prosthesis. Urology 52(2):282–286CrossRefPubMed Govier FE, Gibbons RP, Correa RJ, Pritchett TR, Kramer-Levien D (1998) Mechanical reliability, surgical complications and patients partner satisfaction of the modern three-piece inflatable penile prosthesis. Urology 52(2):282–286CrossRefPubMed
9.
Zurück zum Zitat Montague DK, Angermeier KW, Lakin MM (2001) Penile prosthesis infections. Int J Impot Res 13(6):326–328CrossRefPubMed Montague DK, Angermeier KW, Lakin MM (2001) Penile prosthesis infections. Int J Impot Res 13(6):326–328CrossRefPubMed
10.
Zurück zum Zitat Wilson SK, Zumbe J, Henry GD, Delk JR, Cleves MA (2007) Infection reduction using antibiotic-coated inflatable penile prosthesis. Urology 70(2):337–340CrossRefPubMed Wilson SK, Zumbe J, Henry GD, Delk JR, Cleves MA (2007) Infection reduction using antibiotic-coated inflatable penile prosthesis. Urology 70(2):337–340CrossRefPubMed
11.
Zurück zum Zitat Carson CC III, Mulcahy JJ, Harsch MR (2011) Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup. J Urol 185(2):614–618CrossRefPubMed Carson CC III, Mulcahy JJ, Harsch MR (2011) Long-term infection outcomes after original antibiotic impregnated inflatable penile prosthesis implants: up to 7.7 years of followup. J Urol 185(2):614–618CrossRefPubMed
12.
Zurück zum Zitat Lotan Y, Roehrborn CG, McConnell JD, Hendin BN (2003) Factors influencing the outcomes of penile prosthesis surgery at teaching institutions. Urology 62(5):918–921CrossRefPubMed Lotan Y, Roehrborn CG, McConnell JD, Hendin BN (2003) Factors influencing the outcomes of penile prosthesis surgery at teaching institutions. Urology 62(5):918–921CrossRefPubMed
13.
Zurück zum Zitat Trost L, Hellstrom WJ (2013) History, contemporary outcomes, and future penile prosthesis: a review of the literature. Sex Med Rev 1:150–163CrossRefPubMed Trost L, Hellstrom WJ (2013) History, contemporary outcomes, and future penile prosthesis: a review of the literature. Sex Med Rev 1:150–163CrossRefPubMed
14.
Zurück zum Zitat Eid JF (2016) Penile implant: review of a “No-Touch” technique. Sex Med Rev 4(3):294–300CrossRefPubMed Eid JF (2016) Penile implant: review of a “No-Touch” technique. Sex Med Rev 4(3):294–300CrossRefPubMed
15.
Zurück zum Zitat Ko OS, Bennett NE Jr (2018) Ambicor two-piece inflatable penile prosthesis: background and contemporary outcomes. Sex Med Rev 6(2):319–327CrossRefPubMed Ko OS, Bennett NE Jr (2018) Ambicor two-piece inflatable penile prosthesis: background and contemporary outcomes. Sex Med Rev 6(2):319–327CrossRefPubMed
16.
Zurück zum Zitat Levine LA, Estrada CR, Morgentaler A (2001) Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. J Urol 166(3):932–937CrossRefPubMed Levine LA, Estrada CR, Morgentaler A (2001) Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. J Urol 166(3):932–937CrossRefPubMed
17.
Zurück zum Zitat Lux M, Reyes-Vallejo L, Morgentaler A, Levine LA (2007) Outcomes and satisfaction rates for redesigned 2-piece penile prosthesis. J Urol 177(1):262–266CrossRefPubMed Lux M, Reyes-Vallejo L, Morgentaler A, Levine LA (2007) Outcomes and satisfaction rates for redesigned 2-piece penile prosthesis. J Urol 177(1):262–266CrossRefPubMed
19.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRef
20.
Zurück zum Zitat Quan H, Parsons GA, Ghali WA (2002) Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 40:675–685CrossRefPubMed Quan H, Parsons GA, Ghali WA (2002) Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 40:675–685CrossRefPubMed
21.
Zurück zum Zitat Alwaal A, Harris CR, Hussein AA, Sanford TH, McCulloch CE, Shindel AW, Breyer BN (2015) The decline of inpatient penile prosthesis over the 10-year period, 2000–2010. Sex Med 3(4):280–286CrossRefPubMedPubMedCentral Alwaal A, Harris CR, Hussein AA, Sanford TH, McCulloch CE, Shindel AW, Breyer BN (2015) The decline of inpatient penile prosthesis over the 10-year period, 2000–2010. Sex Med 3(4):280–286CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Radomski SB, Herschorn S (1992) Risk factors associated with penile prosthesis infection. J Urol 147(2):383–385CrossRefPubMed Radomski SB, Herschorn S (1992) Risk factors associated with penile prosthesis infection. J Urol 147(2):383–385CrossRefPubMed
23.
Zurück zum Zitat Cakan M, Demirel F, Karabacak O, Yalçinkaya F, Altuğ U (2003) Risk factors for penile prosthetic infection. Int Urol Nephrol 35(2):209–213CrossRefPubMed Cakan M, Demirel F, Karabacak O, Yalçinkaya F, Altuğ U (2003) Risk factors for penile prosthetic infection. Int Urol Nephrol 35(2):209–213CrossRefPubMed
24.
Zurück zum Zitat Carson CC, Robertson CN (1988) Late hematogenous infection of penile prostheses. J Urol 139(1):50–52CrossRefPubMed Carson CC, Robertson CN (1988) Late hematogenous infection of penile prostheses. J Urol 139(1):50–52CrossRefPubMed
25.
Zurück zum Zitat Little JW, Rhodus NL (1992) The need for antibiotic prophylaxis of patients with penile implants during invasive dental procedures: a national survey of urologists. J Urol 148(6):1801–1804CrossRefPubMed Little JW, Rhodus NL (1992) The need for antibiotic prophylaxis of patients with penile implants during invasive dental procedures: a national survey of urologists. J Urol 148(6):1801–1804CrossRefPubMed
26.
Zurück zum Zitat Wilson SK, Delk JR II (1995) Inflatable penile implant infection: predisposing factors and treatment suggestions. J Urol 153(3 Pt 1):659–661PubMed Wilson SK, Delk JR II (1995) Inflatable penile implant infection: predisposing factors and treatment suggestions. J Urol 153(3 Pt 1):659–661PubMed
27.
Zurück zum Zitat Pineda M, Burnett AL (2016) Penile prosthesis infections—a review of risk factors, prevention, and treatment. Sex Med Rev 4(4):389–398CrossRefPubMed Pineda M, Burnett AL (2016) Penile prosthesis infections—a review of risk factors, prevention, and treatment. Sex Med Rev 4(4):389–398CrossRefPubMed
28.
Zurück zum Zitat Montague DK, Angermeier KW, Lakin MM (2001) Penile prosthesis infections. Int J Impot Res 13(6):323–328CrossRef Montague DK, Angermeier KW, Lakin MM (2001) Penile prosthesis infections. Int J Impot Res 13(6):323–328CrossRef
Metadaten
Titel
Trends in penile prosthesis implantation and analysis of predictive factors for removal
verfasst von
Kai Li
Eileen R. Brandes
Steven L. Chang
Jeffrey J. Leow
Benjamin I. Chung
Ye Wang
Jairam R. Eswara
Publikationsdatum
24.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 4/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2491-4

Weitere Artikel der Ausgabe 4/2019

World Journal of Urology 4/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.